Tamika Mitchell

830 total citations
10 papers, 502 citations indexed

About

Tamika Mitchell is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tamika Mitchell has authored 10 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tamika Mitchell's work include Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Tamika Mitchell is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Tamika Mitchell collaborates with scholars based in United States, United Kingdom and Italy. Tamika Mitchell's co-authors include Rachel Schiff, Martin J. Shea, Sarmistha Nanda, Naomi J. Halas, Amit Joshi, Alexander S. Urban, Ciceron Ayala‐Orozco, Sandra Whaley Bishnoi, Mark W. Knight and Amanda M. Goodman and has published in prestigious journals such as ACS Nano, Cancer Research and Clinical Cancer Research.

In The Last Decade

Tamika Mitchell

10 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamika Mitchell United States 7 299 230 132 115 102 10 502
Sarmistha Nanda United States 8 297 1.0× 230 1.0× 131 1.0× 174 1.5× 102 1.0× 18 571
Sonia Kumar United States 9 255 0.9× 229 1.0× 121 0.9× 265 2.3× 122 1.2× 17 606
Desiree Van Haute United States 11 404 1.4× 240 1.0× 168 1.3× 436 3.8× 179 1.8× 12 915
Jaesook Park South Korea 10 392 1.3× 162 0.7× 105 0.8× 166 1.4× 230 2.3× 13 589
Dong Peng China 12 413 1.4× 95 0.4× 146 1.1× 188 1.6× 114 1.1× 16 640
Si-Yun Liu China 5 409 1.4× 265 1.2× 207 1.6× 142 1.2× 189 1.9× 7 572
Hazem Karabeber United States 8 477 1.6× 386 1.7× 123 0.9× 342 3.0× 149 1.5× 11 839
Rachana Visaria United States 6 259 0.9× 140 0.6× 130 1.0× 102 0.9× 215 2.1× 10 495
Chiung Wen Kuo Taiwan 16 302 1.0× 93 0.4× 171 1.3× 211 1.8× 114 1.1× 24 702
Hsiao‐Ting Hsu United States 11 412 1.4× 189 0.8× 129 1.0× 262 2.3× 75 0.7× 16 702

Countries citing papers authored by Tamika Mitchell

Since Specialization
Citations

This map shows the geographic impact of Tamika Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamika Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamika Mitchell more than expected).

Fields of papers citing papers by Tamika Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamika Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamika Mitchell. The network helps show where Tamika Mitchell may publish in the future.

Co-authorship network of co-authors of Tamika Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Tamika Mitchell. A scholar is included among the top collaborators of Tamika Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamika Mitchell. Tamika Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wang, Xian, Jamunarani Veeraraghavan, Lanfang Qin, et al.. (2021). Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer. Clinical Cancer Research. 27(9). 2648–2662. 8 indexed citations
2.
Bhat, Raksha R., Lanfang Qin, Suhas Vasaikar, et al.. (2021). A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer. The FASEB Journal. 35(7). e21719–e21719. 16 indexed citations
3.
D’Souza, Nigel, Theo Georgiou Delisle, Sally C. Benton, et al.. (2021). Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study. British journal of surgery. 108(7). 804–810. 22 indexed citations
4.
Veeraraghavan, Jamunarani, Sarmistha Nanda, Vidyalakshmi Sethunath, et al.. (2021). Abstract 1077: Acquired neratinib resistance is associated with acquisition of HER2 and PIK3CA mutations and can be overcome using potent drug combinations in HER2-positive breast cancer models. Cancer Research. 81(13_Supplement). 1077–1077. 1 indexed citations
5.
Veeraraghavan, Jamunarani, Sarmistha Nanda, Vidyalakshmi Sethunath, et al.. (2021). Abstract PD3-09: HER2 L755S mutation is acquired upon resistance to lapatinib and neratinib and confers cross-resistance to tucatinib and trastuzumab in HER2-positive breast cancer cell models. Cancer Research. 81(4_Supplement). PD3–9. 3 indexed citations
6.
Veeraraghavan, Jamunarani, Sarmistha Nanda, Vidyalakshmi Sethunath, et al.. (2020). Abstract 1911: HER2 L755S mutation is associated with acquired resistance to lapatinib and neratinib, and confers cross-resistance to tucatinib in HER2-positive breast cancer models. Cancer Research. 80(16_Supplement). 1911–1911. 10 indexed citations
7.
Nardone, Agostina, Hazel M. Weir, Oona Delpuech, et al.. (2018). The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. British Journal of Cancer. 120(3). 331–339. 43 indexed citations
8.
Ayala‐Orozco, Ciceron, Sandra Whaley Bishnoi, Alexander S. Urban, et al.. (2014). Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors. Journal of Controlled Release. 191. 90–97. 71 indexed citations
9.
Ayala‐Orozco, Ciceron, Mark W. Knight, Alexander S. Urban, et al.. (2014). Au Nanomatryoshkas as Efficient Near-Infrared Photothermal Transducers for Cancer Treatment: Benchmarking against Nanoshells. ACS Nano. 8(6). 6372–6381. 327 indexed citations
10.
Fu, Xuebin, Varun Kumar, Sarmistha Nanda, et al.. (2012). Abstract PD01-01: Overcoming endocrine therapy resistance related to PTEN loss by strategic combinations with mTOR, AKT, or MEK inhibitors. Cancer Research. 72(24_Supplement). PD01–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarmistha Nanda Breakdown of academic impact, for papers by Sonia Kumar Breakdown of academic impact, for papers by Desiree Van Haute Breakdown of academic impact, for papers by Jaesook Park Breakdown of academic impact, for papers by Dong Peng Breakdown of academic impact, for papers by Si-Yun Liu Breakdown of academic impact, for papers by Hazem Karabeber Breakdown of academic impact, for papers by Rachana Visaria Breakdown of academic impact, for papers by Chiung Wen Kuo Breakdown of academic impact, for papers by Hsiao‐Ting Hsu
Rankless by CCL
2026